[Featured Stock] Seegene Soars on News of COVID-19 Diagnostic Reagent Launch

[Asia Economy Reporter Minji Lee] Seegene is experiencing a sharp rise following the news of launching a diagnostic reagent (diagnostic kit) for the novel coronavirus infection (COVID-19) domestically.

At 9:34 AM on the 18th, Seegene was trading at 35,600 KRW on the KOSDAQ market, up 16.15% from the previous session.

On the same day, Seegene announced the domestic launch of the COVID-19 diagnostic reagent 'Allplex 2019-nCoV Assay.' This product received European certification (CE-IVD) and emergency use approval from the Ministry of Food and Drug Safety on the 7th and 12th, respectively.